Metabolic Needs and Capabilities of Toxoplasma gondii through Combined Computational and Experimental Analysis

PLoS Computational Biology

Volumn 11, Issue 5, 2015, Pages

  Tymoshenko, Stepan ^a,b,c   Oppenheim, Rebecca D ^b   Agren, Rasmus ^d   Nielsen, Jens ^d   Soldati Favre, Dominique ^b   Hatzimanikatis, Vassily ^b,c  

^a EPFL   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

^d CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; ENZYMES; METABOLISM;

ACETYL-COA; COMPUTATIONAL ANALYSIS; EXPERIMENTAL ANALYSIS; FLUX BALANCE ANALYSIS; GENOME-SCALE METABOLIC MODELING; HUMAN PATHOGENS; PARASITE-; RECONSTRUCTION ALGORITHMS; RECONSTRUCTION PROCESS; TOXOPLASMA GONDII;

GENES;

ACETYL COENZYME A; ACETYL COENZYME A SYNTHETASE; ADENOSINE TRIPHOSPHATE CITRATE SYNTHASE; GENOMIC DNA; DNA; PROTOZOAL PROTEIN;

ALGORITHM; ARTICLE; BIOMASS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOSOL; GENE SEQUENCE; GENETIC MODEL; GENETIC TRANSFECTION; GENOME; GROWTH; HOST CELL; IMMUNOFLUORESCENCE TEST; METABOLISM; MOLECULAR CLONING; NONHUMAN; NUTRITIONAL REQUIREMENT; PHENOTYPE; PREDICTION; TOXOPLASMA GONDII; WESTERN BLOTTING; AUTOMATION; BIOLOGY; COMPUTER SIMULATION; GENE; GENE DELETION; GENETICS; HOST PARASITE INTERACTION; HUMAN; OPEN READING FRAME; PARASITOLOGY; PROCEDURES; TOXOPLASMA; TOXOPLASMOSIS;

TOXOPLASMA; TOXOPLASMA GONDII;

ACETYL COENZYME A; ALGORITHMS; AUTOMATION; CLONING, MOLECULAR; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; DNA; GENE DELETION; GENES, PROTOZOAN; GENOME; HOST-PARASITE INTERACTIONS; HUMANS; METABOLIC NETWORKS AND PATHWAYS; OPEN READING FRAMES; PHENOTYPE; PROTOZOAN PROTEINS; TOXOPLASMA; TOXOPLASMOSIS;

EID: 84930607857     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1004261     Document Type: Article

References (67)

1. Tenter AM, Heckeroth AR, Weiss LM, (2000) Toxoplasma gondii: from animals to humans. Int J Parasitol 30: 1217–1258. 11113252
2. Weiss LM, Dubey JP, (2009) Toxoplasmosis: A history of clinical observations. Int J Parasitol 39: 895–901. doi: 10.1016/j.ijpara.2009.02.004 19217908
3. Macrae JI, Sheiner L, Nahid A, Tonkin C, Striepen B, et al. (2012) Mitochondrial Metabolism of Glucose and Glutamine Is Required for Intracellular Growth of Toxoplasma gondii. Cell Host Microbe. pp. 682–692.
4. Polonais V, Soldati-Favre D, (2010) Versatility in the acquisition of energy and carbon sources by the Apicomplexa. Biology of the Cell 102: 435–445. doi: 10.1042/BC20100005 20586726
5. Kim HU, Sohn SB, Lee SY, (2012) Metabolic network modeling and simulation for drug targeting and discovery. Biotechnol J 7: 330–342. doi: 10.1002/biot.201100159 22125297
6. Pinney JW, Papp B, Hyland C, Wambua L, Westhead DR, et al. (2007) Metabolic reconstruction and analysis for parasite genomes. Trends in Parasitology 23: 548–554. 17950669
7. Vanee N, Roberts SB, Fong SS, Manque P, Buck GA, (2010) A genome-scale metabolic model of Cryptosporidium hominis. Chem Biodivers 7: 1026–1039. doi: 10.1002/cbdv.200900323 20491062
8. Plata G, Hsiao T-L, Olszewski KL, Llinás M, Vitkup D (2010) Reconstruction and flux-balance analysis of the Plasmodium falciparum metabolic network. Mol Syst Biol. pp. 408.
9. Huthmacher C, Hoppe A, Bulik S, Holzhütter H-G (2010) Antimalarial drug targets in Plasmodium falciparum predicted by stage-specific metabolic network analysis. BMC Syst Biol. pp. 120.
10. Song C, Chiasson MA, Nursimulu N, Hung SS, Wasmuth J, et al. (2013) Metabolic reconstruction identifies strain-specific regulation of virulence in Toxoplasma gondii. Mol Syst Biol. pp. 708.
11. Agren R, Liu L, Shoaie S, Vongsangnak W, Nookaew I, et al. (2013) The RAVEN Toolbox and Its Use for Generating a Genome-scale Metabolic Model for Penicillium chrysogenum. PLoS Comput Biol. pp. e1002980.
12. Thiele I, Palsson BO, (2010) A protocol for generating a high-quality genome-scale metabolic reconstruction. Nature Protocols 5: 93–121. doi: 10.1038/nprot.2009.203 20057383
13. Bazzani S, Hoppe A, Holzhütter H-G (2012) Network-based assessment of the selectivity of metabolic drug targets in Plasmodium falciparum with respect to human liver metabolism. BMC Syst Biol. pp. 118.
14. Cilingir G, Broschat SL, Lau AO, (2012) ApicoAP: the first computational model for identifying apicoplast-targeted proteins in multiple species of Apicomplexa. PLoS One 7: e36598. doi: 10.1371/journal.pone.0036598 22574192
15. Claros MG, Vincens P, (1996) Computational method to predict mitochondrially imported proteins and their targeting sequences. European Journal of Biochemistry 241: 779–786. 8944766
16. Emanuelsson O, Brunak S, von Heijne G, Nielsen H, (2007) Locating proteins in the cell using TargetP, SignalP and related tools. Nat Protoc 2: 953–971. 17446895
17. Ogata H, Goto S, Sato K, Fujibuchi W, Bono H, et al. (1999) KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res 27: 29–34. 9847135
18. Shanmugasundram A, Gonzalez-Galarza FF, Wastling JM, Vasieva O, Jones AR (2012) Library of Apicomplexan Metabolic Pathways: a manually curated database for metabolic pathways of apicomplexan parasites. Nucleic Acids Res. pp. D706-D713.
19. Thiele I, Swainston N, Fleming RMT, Hoppe A, Sahoo S, et al. (2013) A community-driven global reconstruction of human metabolism. Nat Biotechnol. pp. 419–425.
20. Chavali AK, Whittemore JD, Eddy JA, Williams KT, Papin JA, (2008) Systems analysis of metabolism in the pathogenic trypanosomatid Leishmania major. Mol Syst Biol 4: 177. doi: 10.1038/msb.2008.15 18364711
21. Woodcroft BJ, McMillan PJ, Dekiwadia C, Tilley L, Ralph SA (2012) Determination of protein subcellular localization in apicomplexan parasites. Trends Parasitol. pp. 546–554.
22. Pino P, Foth BJ, Kwok L-Y, Sheiner L, Schepers R, et al. (2007) Dual targeting of antioxidant and metabolic enzymes to the mitochondrion and the apicoplast of Toxoplasma gondii. PLoS Pathog. pp. e115.
23. Foth BJ, McFadden GI, (2003) The apicoplast: a plastid in Plasmodium falciparum and other Apicomplexan parasites. Int Rev Cytol 224: 57–110. 12722949
24. Brooks CF, Johnsen H, van Dooren GG, Muthalagi M, Lin SS, et al. (2010) The toxoplasma apicoplast phosphate translocator links cytosolic and apicoplast metabolism and is essential for parasite survival. Cell Host Microbe 7: 62–73. doi: 10.1016/j.chom.2009.12.002 20036630
25. Hunter WN, (2011) Isoprenoid Precursor Biosynthesis Offers Potential Targets for Drug Discovery Against Diseases Caused by Apicomplexan Parasites. Current Topics in Medicinal Chemistry 11: 2048–2059. 21619509
26. Fritz HM, Bowyer PW, Bogyo M, Conrad PA, Boothroyd JC, (2012) Proteomic analysis of fractionated Toxoplasma oocysts reveals clues to their environmental resistance. PLoS One 7: e29955. doi: 10.1371/journal.pone.0029955 22279555
27. Oppenheim RD, Creek DJ, Macrae JI, Modrzynska KK, Pino P, et al. (2014) BCKDH: the missing link in apicomplexan mitochondrial metabolism is required for full virulence of Toxoplasma gondii and Plasmodium berghei. PLoS Pathog 10: e1004263. doi: 10.1371/journal.ppat.1004263 25032958
28. Divakaruni AS, Murphy AN, (2012) Cell biology. A mitochondrial mystery, solved. Science 337: 41–43. doi: 10.1126/science.1225601 22767917
29. Bricker DK, Taylor EB, Schell JC, Orsak T, Boutron A, et al. (2012) A Mitochondrial Pyruvate Carrier Required for Pyruvate Uptake in Yeast, Drosophila, and Humans. Science. pp. 96–100.
30. Herzig S, Raemy E, Montessuit S, Veuthey J-L, Zamboni N, et al. (2012) Identification and Functional Expression of the Mitochondrial Pyruvate Carrier. Science. pp. 93–96.
31. Yardley V, Khan AA, Martin MB, Slifer TR, Araujo FG, et al. (2002) In vivo activities of farnesyl pyrophosphate synthase inhibitors against Leishmania donovani and Toxoplasma gondii. Antimicrobial Agents and Chemotherapy. pp. 929–931.
32. Ling Y, Sahota G, Odeh S, Chan JM, Araujo FG, et al. (2005) Bisphosphonate inhibitors of Toxoplasma gondii growth: in vitro, QSAR, and in vivo investigations. J Med Chem 48: 3130–3140. 15857119
33. Fleige T, Pfaff N, Gross U, Bohne W (2008) Localisation of gluconeogenesis and tricarboxylic acid (TCA)-cycle enzymes and first functional analysis of the TCA cycle in Toxoplasma gondii. International Journal for Parasitology. pp. 1121–1132.
34. Mazumdar J, H Wilson E, Masek K, A Hunter C, Striepen B (2006) Apicoplast fatty acid synthesis is essential for organelle biogenesis and parasite survival in Toxoplasma gondii. Proc Natl Acad Sci USA. pp. 13192–13197.
35. Gupta N, Zahn MM, Coppens I, Joiner KA, Voelker DR, (2005) Selective disruption of phosphatidylcholine metabolism of the intracellular parasite Toxoplasma gondii arrests its growth. J Biol Chem 280: 16345–16353. 15708856
36. Sampels V (2012) Plasticity of the phosphatidylcholine biogenesis in the obligate intracellular Parasite Toxoplasma gondii: Humboldt-Universität zu Berlin, Mathematisch-Naturwissenschaftliche Fakultät I, PhD thesis, Available: http://edoc.hu-berlin.de/dissertationen/sampels-vera-2012-03-27/PDF/sampels.pdf
37. Anderson AC, (2005) Targeting DHFR in parasitic protozoa. Drug Discov Today 10: 121–128. 15718161
38. Tymoshenko S, Oppenheim RD, Soldati-Favre D, Hatzimanikatis V (2013) Functional genomics of Plasmodium falciparum using metabolic modelling and analysis. Briefings in functional genomics. pp. 316–327.
39. Feist AM, Palsson BO, (2010) The biomass objective function. Current Opinion in Microbiology 13: 344–349. doi: 10.1016/j.mib.2010.03.003 20430689
40. Jonas MC, Pehar M, Puglielli L, (2010) AT-1 is the ER membrane acetyl-CoA transporter and is essential for cell viability. Journal of Cell Science 123: 3378–3388. doi: 10.1242/jcs.068841 20826464
41. Pieperhoff MS, Pall GS, Jimenez-Ruis E, Das S, Wong EH, et al. (2014) Conditional U1 Gene Silencing in Toxoplasma gondii, Preprint, Available: http://biorxiv.org/biorxiv/early/2014/09/01/008649.full.pdf. Accessed 01.11.2014
42. Shen B, Brown KM, Lee TD, Sibley LD, (2014) Efficient Gene Disruption in Diverse Strains of Toxoplasma gondii Using CRISPR/CAS9. Mbio 5: e01114–01114. doi: 10.1128/mBio.01114-14 24825012
43. Nielsen J, Jewett MC, (2008) Impact of systems biology on metabolic engineering of Saccharomyces cerevisiae. FEMS Yeast Res 8: 122–131. 17727659
44. Forth T (2012) Metabolic systems biology of the malaria parasite: reconstruction, visualisation and analysis of an experimentally parameterised metabolic model of the human acute malaria parasite Plasmodium falciparum, PhD thesis, University of Leeds, Available: http://etheses.whiterose.ac.uk/3739/
45. Blume M, Rodriguez-Contreras D (2009) Host-derived glucose and its transporter in the obligate intracellular pathogen Toxoplasma gondii are dispensable by glutaminolysis. PNAS. pp. 12998–13003.
46. Lee IP, Evans AK, Yang C, Works MG, Kumar V, et al. (2014) Toxoplasma gondii Is Dependent on Glutamine and Alters Migratory Profile of Infected Host Bone Marrow Derived Immune Cells through SNAT2 and CXCR4 Pathways. Plos One 9: e109803. doi: 10.1371/journal.pone.0109803 25299045
47. Gille C, Bölling C, Hoppe A, Bulik S, Hoffmann S, et al. (2010) HepatoNet1: a comprehensive metabolic reconstruction of the human hepatocyte for the analysis of liver physiology. Mol Syst Biol. pp. 411.
48. Mardinoglu A, Agren R, Kampf C, Asplund A, Uhlen M, et al. (2014) Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease. Nat Commun 5: 3083. doi: 10.1038/ncomms4083 24419221
49. Reeds PJ, (2000) Dispensable and indispensable amino acids for humans. J Nutr 130: 1835S–1840S. 10867060
50. Possenti A, Fratini F, Fantozzi L, Pozio E, Dubey JP, et al. (2013) Global proteomic analysis of the oocyst/sporozoite of Toxoplasma gondii reveals commitment to a host-independent lifestyle. BMC Genomics 14: 183. doi: 10.1186/1471-2164-14-183 23496850
51. Torrey EF, Yolken RH, (2013) Toxoplasma oocysts as a public health problem. Trends in Parasitology 29: 380–384. doi: 10.1016/j.pt.2013.06.001 23849140
52. Fox BA, Bzik DJ (2010) Avirulent Uracil Auxotrophs Based on Disruption of Orotidine-5'-Monophosphate Decarboxylase Elicit Protective Immunity to Toxoplasma gondii. Infection and Immunity. pp. 3744–3752.
53. Gautam B, Singh G, Wadhwa G, Farmer R, Singh S, et al. (2012) Metabolic pathway analysis and molecular docking analysis for identification of putative drug targets in Toxoplasma gondii: novel approach. Bioinformation 8: 134–141. 22368385
54. Herrgard MJ, Swainston N, Dobson P, Dunn WB, Arga KY, et al. (2008) A consensus yeast metabolic network reconstruction obtained from a community approach to systems biology. Nature Biotechnology 26: 1155–1160. doi: 10.1038/nbt1492 18846089
55. Ramakrishnan S, Docampo MD, MacRae JI, Pujol FM, Brooks CF, et al. (2012) Apicoplast and Endoplasmic Reticulum Cooperate in Fatty Acid Biosynthesis in Apicomplexan Parasite Toxoplasma gondii. Journal of Biological Chemistry. pp. 4957–4971.
56. Fleige T, Fischer K, Ferguson DJP, Gross U, Bohne W (2007) Carbohydrate Metabolism in the Toxoplasma gondii Apicoplast: Localization of Three Glycolytic Isoenzymes, the Single Pyruvate Dehydrogenase Complex, and a Plastid Phosphate Translocator. Eukaryotic Cell. pp. 984–996.
57. Gajria B, Bahl A, Brestelli J, Dommer J (2008) ToxoDB: an integrated Toxoplasma gondii database resource. Nucleic Acids Res. pp. D553-D556.
58. Perrotto J, Keister DB, Gelderma Ah, (1971) Incorporation of Precursors into Toxoplasma DNA. Journal of Protozoology 18: 470–473. 5132320
59. Schwab JC, Beckers CJ, Joiner KA (1994) The parasitophorous vacuole membrane surrounding intracellular Toxoplasma gondii functions as a molecular sieve. Proc Natl Acad Sci USA. pp. 509–513.
60. Orth JD, Thiele I, Palsson BO, (2010) What is flux balance analysis? Nat Biotechnol 28: 245–248. doi: 10.1038/nbt.1614 20212490
61. Joyce AR, Palsson BØ, (2008) Predicting gene essentiality using genome-scale in silico models. Microbial Gene Essentiality: Protocols and Bioinformatics: Springer. pp. 433–457.
62. Sheiner L, Santos JM, Klages N, Parussini F, Jemmely N, et al. (2010) Toxoplasma gondii transmembrane microneme proteins and their modular design. Molecular Microbiology 77: 912–929.
63. Soldati D, Boothroyd JC (1993) Transient transfection and expression in the obligate intracellular parasite Toxoplasma gondii. Science. pp. 349–352.
64. Donald RGK, Carter D, Ullman B, Roos DS, (1996) Insertional tagging, cloning, and expression of the Toxoplasma gondii hypoxanthine-xanthine-guanine phosphoribosyltransferase gene—Use as a selectable marker for stable transformation. Journal of Biological Chemistry 271: 14010–14019. 8662859
65. Plattner F, Yarovinsky F, Romero S, Didry D, Carlier MF, et al. (2008) Toxoplasma profilin is essential for host cell invasion and TLR11-dependent induction of an interleukin-12 response. Cell Host & Microbe 3: 77–87.
66. DeRocher AE, Coppens I, Karnataki A, Gilbert LA, Rome ME, et al. (2008) A thioredoxin family protein of the apicoplast periphery identifies abundant candidate transport vesicles in Toxoplasma gondii. Eukaryotic Cell 7: 1518–1529. doi: 10.1128/EC.00081-08 18586952
67. Hettmann C, Herm A, Geiter A, Frank B, Schwarz E, et al. (2000) A dibasic motif in the tail of a class XIV apicomplexan myosin is an essential determinant of plasma membrane localization. Molecular Biology of the Cell 11: 1385–1400. 10749937